Philippe Danjou
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Pathway to Proof-of-Concept for BNC210, a Negative Allosteric Modulator of the Alpha-7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease.
Journal: Clinical pharmacology in drug development
Published: July 08, 2025
Correction: Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.
Journal: Translational psychiatry
Published: May 11, 2021
Cholinergic modulation of disorder-relevant human defensive behaviour in generalised anxiety disorder.
Journal: Translational psychiatry
Published: June 09, 2020
Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.
Journal: Translational psychiatry
Published: February 07, 2020
Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings - A Randomized, Crossover Trial in Healthy Males.
Journal: Neuroscience
Published: July 12, 2019
Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder.
Journal: Biological psychiatry
Published: May 21, 2019
Pre-intervention test-retest reliability of EEG and ERP over four recording intervals.
Journal: International journal of psychophysiology : official journal of the International Organization of Psychophysiology
Published: February 09, 2018
A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
Journal: Expert review of neurotherapeutics
Published: February 01, 2012
Effects of prolonged-release melatonin and zolpidem on postural stability in older adults.
Journal: Human psychopharmacology
Published: October 03, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026